Cite
Longer Term Follow-up on the First Patients with Severe Hemoglobinopathies Treated with Lentiglobin Gene Therapy
MLA
Cavazzana, Marina, et al. “Longer Term Follow-up on the First Patients with Severe Hemoglobinopathies Treated with Lentiglobin Gene Therapy.” Blood, vol. 130, no. 1, Number 1 Supplement 1, Dec. 2017, p. 4609. EBSCOhost, https://doi.org/10.1182/blood.V130.Suppl_1.4609.4609.
APA
Cavazzana, M., Hacein-Bey-Abina, S., Payen, E., Magrin, E., Magnani, A., Semeraro, M., Caccavelli, L., Touzot, F., Lefrere, F., Suarez, F., Hermine, O., Brousse, V., Poirot, C., Moshous, D., Bourget, P., El Nemer, W., Bartolucci, P., Weber, L., Puy, H., … Ribeil, J.-A. (2017). Longer Term Follow-up on the First Patients with Severe Hemoglobinopathies Treated with Lentiglobin Gene Therapy. Blood, 130(1, Number 1 Supplement 1), 4609. https://doi.org/10.1182/blood.V130.Suppl_1.4609.4609
Chicago
Cavazzana, Marina, Salima Hacein-Bey-Abina, Emmanuel Payen, Elisa Magrin, Alessandra Magnani, Michaela Semeraro, Laure Caccavelli, et al. 2017. “Longer Term Follow-up on the First Patients with Severe Hemoglobinopathies Treated with Lentiglobin Gene Therapy.” Blood 130 (1, Number 1 Supplement 1): 4609. doi:10.1182/blood.V130.Suppl_1.4609.4609.